Dendritic cells form clusters in vivo, but the mechanism behind this has not been determined. In this article, we demonstrate that monocytes from mice deficient in the chemokine receptors CCR1, CCR2, CCR3, and CCR5 display reduced clustering in vitro, which is associated with impaired dendritic cell and macrophage differentiation. We further show that the differentiating cells themselves produce ligands for these receptors that function, in a redundant manner, to regulate cell clustering. Deletion of, or pharmacological blockade of, more than one of these receptors is required to impair clustering and differentiation. Our data show that chemokines and their receptors support clustering by increasing expression of, and activating, cell-surfa...
Inflammatory (classical) monocytes residing in the bone marrow must enter the bloodstream in order t...
Background: The recruitment of mononuclear cells has important implications for tissue inflammation...
Despite over 20 years of pharmaceutical targeted research, no antagonist of inflammatory chemokine r...
Currently, we lack an understanding of the individual and combinatorial roles for chemokine receptor...
Chemokines and their receptors collectively orchestrate the trafficking of leukocytes in normal immu...
Macrophages are central to both innate and adaptive immunity. With few exceptions, macrophages are t...
Macrophages are central to both innate and adaptive immunity. With few exceptions, macrophages are t...
The present study addressed the modulatory role of CC chemokine receptor 4 (CCR4) in Toll-like recep...
CC chemokine receptor 2 (CCR2) is a prominent receptor for the monocyte chemoattractant protein (MCP...
CC chemokine receptor 2 (CCR2) is a prominent receptor for the monocyte chemoattractant protein (MCP...
Background: The recruitment of mononuclear cells has important implications for tissue inflammation...
Macrophages regulate lymphatic vasculature development; however, the molecular mechanisms regulating...
Dendritic cells (DCs) are potent antigen presenting cells, described as the initiators of adaptive i...
Macrophages have emerged as a key component of the innate immune system that emigrates to peripheral...
Macrophages regulate lymphatic vasculature development; however, the molecular mechanisms regulating...
Inflammatory (classical) monocytes residing in the bone marrow must enter the bloodstream in order t...
Background: The recruitment of mononuclear cells has important implications for tissue inflammation...
Despite over 20 years of pharmaceutical targeted research, no antagonist of inflammatory chemokine r...
Currently, we lack an understanding of the individual and combinatorial roles for chemokine receptor...
Chemokines and their receptors collectively orchestrate the trafficking of leukocytes in normal immu...
Macrophages are central to both innate and adaptive immunity. With few exceptions, macrophages are t...
Macrophages are central to both innate and adaptive immunity. With few exceptions, macrophages are t...
The present study addressed the modulatory role of CC chemokine receptor 4 (CCR4) in Toll-like recep...
CC chemokine receptor 2 (CCR2) is a prominent receptor for the monocyte chemoattractant protein (MCP...
CC chemokine receptor 2 (CCR2) is a prominent receptor for the monocyte chemoattractant protein (MCP...
Background: The recruitment of mononuclear cells has important implications for tissue inflammation...
Macrophages regulate lymphatic vasculature development; however, the molecular mechanisms regulating...
Dendritic cells (DCs) are potent antigen presenting cells, described as the initiators of adaptive i...
Macrophages have emerged as a key component of the innate immune system that emigrates to peripheral...
Macrophages regulate lymphatic vasculature development; however, the molecular mechanisms regulating...
Inflammatory (classical) monocytes residing in the bone marrow must enter the bloodstream in order t...
Background: The recruitment of mononuclear cells has important implications for tissue inflammation...
Despite over 20 years of pharmaceutical targeted research, no antagonist of inflammatory chemokine r...